I appreciate your response, Spudd.
While there are numbers in your citation, they revolve around a plea for trust and are not results of any sort of study.
The only germane numbers I have seen are a really small group studied by Pfizer. There could be more so citations would be appreciated.
N = 1678 (3 doses, age 0.5 to 5y)
Cases = 3 (with vax), 7 (with placebo)
Notice, this isn't deaths. These are cases.
Cite:
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose | Pfizer
They seem to be suggesting this proves 80.3% efficacy against all strains but I don't see any evidence of an antibody study to determine how many of them had natural immunity prior to the test. Surely, by now, a whole lot of them will have had COVID exposure.
"This descriptive analysis was based on 10 symptomatic COVID-19 cases identified from seven days after the third dose and accrued as of April 29, 2022. The trial protocol specifies a formal analysis will be performed when at least 21 cases have accrued from seven days after the third dose. Final vaccine efficacy data will be shared once available."
So, the trial is not done, as far as I know.
I have zero interest in pleas to trust the FDA/CDC/Phizer. Zero. They are going to have to be more forthcoming with statistics. If they were more trustworthy, they would spend less energy asking us to trust them and more energy sharing actual data and risk analysis.